Thursday , November 28 2024
Home / Mike Norman Economics / Marita Moloney – Call for supplements to be regulated after research found 65% of products tested didn’t meet claims

Marita Moloney – Call for supplements to be regulated after research found 65% of products tested didn’t meet claims

Summary:
The health and wellness industry is a multi-billion euro operation, but some areas such as supplements are unregulatedRegulation will shoot the price right up, but if you are buying rubbish, not only is it expensive (you're paying a lot for the small amount you do get), it's not doing much anyway. There are good brands out there, but the European ones tend to be expensive, although over years a top quality American brand has become very competitive. Over 20 years of research, Professor Nolan and his colleagues established that by enriching patients with macular degeneration, it reduces their risk of going blind.He added: "Knowing that, thereafter, it's really important that we have a quality of supplement that's out there, because if a patient is consuming a supplement that doesn't have

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

Lars Pålsson Syll writes Busting the ‘natural rate of unemployment’ myth

Mike Norman writes Rates

Michael Hudson writes Petrodollar Deal or No Deal

Lars Pålsson Syll writes Riksbankens oansvariga penningpolitik

 The health and wellness industry is a multi-billion euro operation, but some areas such as supplements are unregulated


Regulation will shoot the price right up, but if you are buying rubbish, not only is it expensive (you're paying a lot for the small amount you do get), it's not doing much anyway. 

There are good brands out there, but the European ones tend to be expensive, although over years a top quality American brand has become very competitive. 

Over 20 years of research, Professor Nolan and his colleagues established that by enriching patients with macular degeneration, it reduces their risk of going blind.

He added: "Knowing that, thereafter, it's really important that we have a quality of supplement that's out there, because if a patient is consuming a supplement that doesn't have the ingredient or the active components, it's not going to have any of the benefits that we've been able to demonstrate through our science or research.

"That's truly not acceptable, so we have a problem in what I would say is an underregulated situation because these nutrients are not viewed as medicines."


NewsTalk


Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *